Microvast WKN: A3CV9D ISIN: US59516C1062 Forum: Aktien User: WALL.E

Steigt Null,enttäuschend.....

Im großen und ganzen sind die Zahlen positiv eine Umsatzsteigerung von 35% zu 2021 ,und die Entwicklung ist Top.👍🏼 (Yang Wu)Wir freuen uns auf das kommende Jahr, da wir unsere neuen Batterietechnologien in die Serienproduktion bringen und bereits eine erhebliche Nachfrage bei unseren Kunden für Nutzfahrzeuge und Energiespeichersysteme haben.“

Ist noch immer grün. 😅

Afterhour sieht ganz gut aus

Was waren das für Zeiten als sich alle über Jonas Kursziel von 4$ lustig gemacht haben…da lag er wohl tatsächlich voll daneben

Die Präsentation gefällt mir gut. Fehlen noch 1-2 dicke Fische als Kunden 😊

Solid cash position – $327.7M cash (includes short -term investment) und wo liegt die Marketcap 370 oder so

+4% jetzt

Aktie immer noch unverändert? 😳

präsentation für den call

https://ir.microvast.com/static-files/0c5387ae-c1db-4fe3-b5f1-2e8c447fc37d

https://ir.microvast.com/news-releases/news-release-details/microvast-reports-2022-financial-results/

https://ibb.co/NLQzbLR

Full Year 2022 Highlights Revenue of $204.5 million, compared to $152.0 million in 2021, an increase of 35% Gross profit increased by 121% to $9.1 million from gross loss of $42.7 million in 2021; Non-GAAP adjusted gross profit of $16.8 million, compared to non-GAAP adjusted gross loss of $38.5 million in 2021; Non-GAAP adjusted gross margin increased to 8.2%, up from negative 25.3% in 2021 Operating expenses of $170.7 million, compared to $157.4 million in 2021; Adjusted operating expenses of $96.5 million, compared to $97.6 million in 2021 Net loss of $158.2 million, compared to net loss of $206.5 million in 2021; Non-GAAP adjusted net loss of $77.3 million, compared to non-GAAP adjusted net loss of $135.0 million in 2021 Adjusted EBITDA of negative $56.7 million, compared to Adjusted EBITDA of negative $109.3 million in 2021 Backlog as of December 31, 2022 was $410.5 million, representing growth of 258.5% compared to $114.5 million in backlog as of December 31, 2021 and sequential growth of 192.0% compared to $140.6 million in backlog at September 30, 2022. Capital expenditures of $150.9 million, compared to $87.9 million in 2021, driven by investments in manufacturing capacity expansions in Huzhou, China and Clarksville, Tennessee Cash, cash equivalents, restricted cash and short-term investment of $327.7 million as of December 31, 2022

35% year over year increase in revenue 121% year over year increase in gross profit >3.5x year over year increase in backlog to $410.5 million